Rethinking governance of synthetic cells

Area of Science:

• Synthetic biology
• Biotechnology governance
• Biosafety and biosecurity

Background:

• Synthetic cells are engineered biological systems with increasing complexity, enabled by advances in synthetic nucleic acid technologies.
• Existing biotechnology governance frameworks face limitations due to the programmability and design space expansion offered by these technologies.
• Advances in nucleic acid synthesis and design are creating novel biosafety and biosecurity concerns.

Purpose of the Study:

• To analyze the limitations of conventional biotechnology governance in the context of synthetic cells.
• To highlight how nucleic acid-enabled advancements challenge existing oversight approaches.
• To propose improvements for risk assessment and governance alignment in synthetic biology.

Main Methods:

• Analysis of synthetic cells as a boundary case for governance limitations.
• Application of a property-based framework from a National Academies report.
• Examination of governance misalignment through triggers, institutional boundaries, and oversight timing.
• Review of current risk assessment approaches and proposal of structured evaluation questions.

Main Results:

• Synthetic cells expose limitations in sequence- and organism-based oversight.
• Governance misalignment occurs due to categorical triggers, institutional boundaries, and timing.
• Current risk assessment methods are insufficient for evaluating synthetic biological systems.
• A need exists for improved, function- and context-based risk assessments.

Conclusions:

• Governance approaches must align with the properties, intended use, and context of engineered biological systems.
• Adaptive governance is crucial as synthetic biology expands beyond conventional biological categories.
• Structured questions can enhance benefit-risk evaluations for consistency across settings.